Alzheimer’s Drug In Development, Lecanemab, May Benefit Some Patients But Carries Risks of Brain Swelling and Bleeding nytimes.com Submitted by Relevant_synapse t3_z8ez5o on November 30, 2022 at 2:51 AM in science 90 comments 923